Published in Heart Rhythm on January 24, 2015
Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' views. BMC Med Genomics (2016) 0.81
Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death Cases. Front Cardiovasc Med (2016) 0.77
Challenges in Molecular Diagnostics of Channelopathies in the Next-Generation Sequencing Era: Less Is More? Front Cardiovasc Med (2016) 0.75
An Autopsy Case of Sudden Unexpected Death of a Young Adult in a Hot Bath: Molecular Analysis Using Next-Generation DNA Sequencing. Clin Med Insights Case Rep (2017) 0.75
Molecular genetic diagnostics for ventricular arrhythmias and sudden cardiac death syndromes. Herz (2017) 0.75
Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians. Curr Cardiol Rep (2017) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
The sequence of the human genome. Science (2001) 101.55
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36
Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature (1953) 47.27
Finishing the euchromatic sequence of the human genome. Nature (2004) 41.40
Sequencing technologies - the next generation. Nat Rev Genet (2009) 40.57
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet (2011) 14.29
Emerging technologies in DNA sequencing. Genome Res (2005) 10.64
Architecture of the human regulatory network derived from ENCODE data. Nature (2012) 10.28
Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet (2011) 6.52
Molecular findings among patients referred for clinical whole-exome sequencing. JAMA (2014) 6.46
Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation (2002) 5.94
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet (2013) 4.06
Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet (2013) 3.30
Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation (2007) 2.88
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm (2009) 2.81
Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol (2013) 2.34
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol (2011) 2.31
DNA sequencing: bench to bedside and beyond. Nucleic Acids Res (2007) 2.25
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol (2012) 2.25
Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation (2002) 2.20
Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol (2012) 1.97
New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet (2013) 1.80
High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet (2012) 1.58
Escape capture bigeminy: phenotypic marker of cardiac sodium channel voltage sensor mutation R222Q. Heart Rhythm (2012) 1.53
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res (2011) 1.51
Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. Am J Hum Genet (2014) 1.35
The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med (2014) 1.34
Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26
Genetic testing for inherited cardiac disease. Nat Rev Cardiol (2013) 1.20
New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia. Circ Cardiovasc Genet (2013) 1.09
R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. J Am Coll Cardiol (2012) 1.07
Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. Heart Rhythm (2014) 1.05
Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience. Circulation (2013) 1.02
Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy. J Am Coll Cardiol (2012) 1.01
Genetic testing in cardiovascular medicine: current landscape and future horizons. Curr Opin Cardiol (2013) 0.96
Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet (2012) 0.78